iPS

Stammzellen - die Zukunft: Eine Einfuehrung zum Thema iPS-Zellen [video]

Last updated:
26 Nov 2012

In diesem eindrücklichen und verständlichen 16 minütigen Film, erzählen führende Wissenschaftler von der Geschichte der induzierten pluripotenten Stammzelle (iPS Zelle) - eine aussergewöhnliche wissenschaftliche Entdeckung, die die Art wie wir Humanbiologie betrachten, grundlegend verändert hat, und für die Shinya Yamanaka und John Gurdon 2012 den Nobelpreis für Medizin verliehen bekommen haben.

Cellule staminali - il futuro : introduzione alle cellule iPS [video]

Last updated:
26 Nov 2012

In questo affascinante e semplice video di 16 minuti, eminenti scienziati raccontano la storia delle cellule staminali pluripotenti indotte (cellule iPS).
Questa straordinaria scoperta scientifica ha cambiato la nostra visione della biologia umana ed ha portato all’assegnazione del Premio Nobel per la Medicina a John Gurdon e Shinya Yamanaka nel 2012.

 

Células madre - el futuro : una introducción a las células iPS [video]

Last updated:
26 Nov 2012

En este fascinante y clara vídeo de 16 minutos, científicos destacados cuentan la historia de las células madre pluripotentes inducidas (células iPS); un descubrimiento científico extraordinario que ha cambiado nuestra percepción de la biología humana y dio lugar a que Shinya Yamanaka fuese galardonado con el Premio Nobel de Medicina, compartido con John Gurdon, en 2012.

Komórki macierzyste – nasza przyszłość: wprowadzenie do tematyki indukowanych pluripotencjalnych komórek macierzystych [video]

Last updated:
26 Nov 2012

W tym przykuwającym uwagę szesnastominutowym filmie wiodący naukowcy opowiadają historię indukowanych pluripotencjalnych komórek macierzystych (komórek iPS). To niezwykłe odkrycie naukowe zmieniło całkowicie sposób myślenia o biologii człowieka. Za to odkrycie Shinya Yamanaka wraz z Johnem Gurdonem zostali uhonorowani nagrodą Nobla w dziedzinie medycyny w 2012 roku.

Renowned experts offer advice on generating human induced pluripotent stem cell banks

Procedures for production of induced pluripotent stem (iPS) cells for use in therapy are reaching the point at which they will be suitable for use in clinical trials.
 
A team of internationally renowned scientists led by the MRC Centre for Regenerative Medicine’s Emeritus Professor Sir Ian Wilmut have today published an opinion piece in the journal CellStemCell, arguing that while in the future it might be possible to derive iPS cell lines on an individual basis – so that a patient would receive his or her own cells as a treatment – it seems unlikely that these will be used as a source for large numbers of patients in the near future due to time and cost restraints.

Cellule souches - le futur: une introduction aux cellules iPS [video]

Last updated:
26 Nov 2012

Dans cette vidéo fascinante de 16 minutes, d'éminents scientifiques racontent l'histoire des cellules souches pluripotentes induites (cellules iPS).
Cette découverte scientifique extraordinaire a changé notre perception de la biologie humaine et résultat à l'attribution du prix Nobel de médecine pour Shinya Yamanaka et John Gurdon, en 2012.

Scottish Stem Cell Stories: A graphic short story of stem cell research

Last updated:
26 Sep 2013

Making blood from stem cells, iPS cells from skin cells and improving the lives of those with diabetes are just a few of the stories that are touched on in this delightful comic. A colourful and enticing introduction to some of the stem cell research happening in Scotland and the directions the science is taking. Ideal for use in the classroom, at festivals and events.

Animation: Disease modelling with cells

How are stem cells used to model disease in the laboratory? This 3-minute animation gives a clear, simple and visually appealing explanation of what disease modelling is, why it is useful and how it is done.

This animation was created for EuroStemCell by animator Duncan Brown, with scientific content by researcher Dr Christian Unger and voiceover by Dr Nathan Adams. It is supported by an accompanying factsheet on reprogrammed cells in disease modelling.

Reprogramming cells: new research reveals a detour on the path to iPS cells

Reprogramming allows us to turn any cell of the body into a stem cell. Since its discovery in 2006 the technique has become widely used in labs around the world. But the process is inefficient and many questions remain about how reprogramming works. PhD student James O'Malley is studying some of these challenging issues. Here he talks about his latest findings, which were published in the journal Nature on 2 June 2013.

Etyka i przeprogramowanie: pytania natury etycznej po odkryciu komórek iPS

Last updated:
26 Nov 2012

Przeprogramowanie pozwala nam zmienić dowolną komórkę ciała w komórkę macierzystą. To odkrycie zaskoczyło wielu naukowców i zmieniło ich sposób postrzegania rozwoju komórek macierzystych. Czy nowa technologia zmienia również dyskusję etyczną dotyczącą badań nad komórkami macierzystymi? Jakie nowe pytania powstają?

Syndicate content